Invesco’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233M | Sell |
12,818,141
-48,763
| -0.4% | -$888K | 0.04% | 570 |
|
|
2025
Q1 | $255M | Buy |
12,866,904
+1,570,649
| +14% | +$31.2M | 0.05% | 505 |
|
|
2024
Q4 | $194M | Sell |
11,296,255
-1,323,514
| -10% | -$22.7M | 0.04% | 638 |
|
|
2024
Q3 | $252M | Sell |
12,619,769
-550,967
| -4% | -$11M | 0.05% | 511 |
|
|
2024
Q2 | $147M | Buy |
13,170,736
+5,366,509
| +69% | +$60M | 0.03% | 672 |
|
|
2024
Q1 | $51.5M | Buy |
7,804,227
+1,692,454
| +28% | +$11.2M | 0.01% | 1014 |
|
|
2023
Q4 | $27.6M | Buy |
6,111,773
+694,607
| +13% | +$3.14M | 0.01% | 1255 |
|
|
2023
Q3 | $19.4M | Buy |
5,417,166
+426,446
| +9% | +$1.53M | 0.01% | 1355 |
|
|
2023
Q2 | $18.4M | Buy |
4,990,720
+164,104
| +3% | +$606K | ﹤0.01% | 1412 |
|
|
2023
Q1 | $16M | Buy |
4,826,616
+615,141
| +15% | +$2.04M | ﹤0.01% | 1469 |
|
|
2022
Q4 | $16.3M | Buy |
4,211,475
+785,726
| +23% | +$3.05M | ﹤0.01% | 1489 |
|
|
2022
Q3 | $8.33M | Buy |
3,425,749
+3,109,896
| +985% | +$7.56M | ﹤0.01% | 1913 |
|
|
2022
Q2 | $625K | Sell |
315,853
-113,610
| -26% | -$225K | ﹤0.01% | 3206 |
|
|
2022
Q1 | $786K | Sell |
429,463
-130,463
| -23% | -$239K | ﹤0.01% | 3159 |
|
|
2021
Q4 | $789K | Buy |
+559,926
| New | +$789K | ﹤0.01% | 3157 |
|
|
2021
Q2 | – | Sell |
-17,896
| Closed | -$31K | – | 3930 |
|
|
2021
Q1 | $31K | Buy |
17,896
+3,602
| +25% | +$6.24K | ﹤0.01% | 3825 |
|
|
2020
Q4 | $28K | Buy |
+14,294
| New | +$28K | ﹤0.01% | 3716 |
|
|
2019
Q4 | – | Sell |
-162,632
| Closed | -$724K | – | 3592 |
|
|
2019
Q3 | $724K | Buy |
+162,632
| New | +$724K | ﹤0.01% | 3108 |
|
|
2019
Q2 | – | Sell |
-54,729
| Closed | -$207K | – | 3662 |
|
|
2019
Q1 | $207K | Buy |
54,729
+4,422
| +9% | +$16.7K | ﹤0.01% | 3578 |
|
|
2018
Q4 | $120K | Sell |
50,307
-11,099
| -18% | -$26.5K | ﹤0.01% | 3591 |
|
|
2018
Q3 | $381K | Buy |
61,406
+15,133
| +33% | +$93.9K | ﹤0.01% | 3498 |
|
|
2018
Q2 | $209K | Buy |
+46,273
| New | +$209K | ﹤0.01% | 3665 |
|